These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7335622)

  • 41. ["Torsades de pointe' induced or stimullated by prenylamine. Apropos of 4 cases].
    Normand JP; Kahn JC; Mialet G; Bardet G; Bourdarias JP; Mathivat A
    Ann Cardiol Angeiol (Paris); 1974; 23(6):527-33. PubMed ID: 4460841
    [No Abstract]   [Full Text] [Related]  

  • 42. Sotalol-induced torsades de pointes in patients with renal failure.
    Dancey D; Wulffhart Z; McEwan P
    Can J Cardiol; 1997 Jan; 13(1):55-8. PubMed ID: 9039065
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Amiodarone therapy after sotalol-induced torsade de pointes: prolonged QT interval and QT dispersion in differentiation of pro-arrhythmic effects].
    van de Loo A; Klingenheben T; Hohnloser SH
    Z Kardiol; 1994 Dec; 83(12):887-90. PubMed ID: 7846927
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ketoconazole induced torsades de pointes without concomitant use of QT interval-prolonging drug.
    Mok NS; Lo YK; Tsui PT; Lam CW
    J Cardiovasc Electrophysiol; 2005 Dec; 16(12):1375-7. PubMed ID: 16403073
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Drug-induced long QT syndrome and torsade de pointes.
    Morissette P; Hreiche R; Turgeon J
    Can J Cardiol; 2005 Aug; 21(10):857-64. PubMed ID: 16107909
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Torsades de Pointes: a cause of syncope in sinus node dysfunction].
    Velázquez Rodríguez E; Rangel Rojo J; Ortega Sánchez A; Zamudio Villafuerte A; González Gallardo S
    Arch Inst Cardiol Mex; 1998; 68(6):498-505. PubMed ID: 10365226
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chronic methadone therapy complicated by torsades de pointes: a case report.
    Pimentel L; Mayo D
    J Emerg Med; 2008 Apr; 34(3):287-90. PubMed ID: 18022786
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ECG of the month. Twisting and turning. Torsades de pointes.
    Martinez-Lopez JI
    J La State Med Soc; 1988 Oct; 140(10):11-3. PubMed ID: 3183481
    [No Abstract]   [Full Text] [Related]  

  • 49. Basic mechanisms underlying prenylamine-induced 'torsade de pointes': differences between prenylamine and fendiline due to basic actions of the isomers.
    Bayer R; Schwarzmaier J; Pernice R
    Curr Med Res Opin; 1988; 11(4):254-72. PubMed ID: 3063437
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Polymorphous ventricular tachycardia in patients receiving prenylamine].
    Sclarowsky S; Damian A; Krakoff O; Lewin RF; Agmon J
    Harefuah; 1979 Mar; 96(5):227-9. PubMed ID: 540807
    [No Abstract]   [Full Text] [Related]  

  • 51. [Bepridil and torsades de pointes].
    Leclercq JF; Kural S; Valère PE
    Arch Mal Coeur Vaiss; 1983 Mar; 76(3):341-8. PubMed ID: 6409035
    [No Abstract]   [Full Text] [Related]  

  • 52. [Suicidal prenylamine-(segontin-) intoxication].
    Beck OA; Hochrein H
    Dtsch Med Wochenschr; 1971 Oct; 96(41):1614-5. PubMed ID: 5098766
    [No Abstract]   [Full Text] [Related]  

  • 53. QT prolongation and recurrent "torsades de pointes" during erythromycin lactobionate infusion.
    Guelon D; Bedock B; Chartier C; Haberer JP
    Am J Cardiol; 1986 Sep; 58(7):666. PubMed ID: 3751946
    [No Abstract]   [Full Text] [Related]  

  • 54. [Repeated syncopes during prolonged treatment with prenylamine (Segontine 60)].
    Picard R; Auzepy P; Chauvin JP
    Presse Med (1893); 1971 Jan; 79(4):145. PubMed ID: 5540292
    [No Abstract]   [Full Text] [Related]  

  • 55. Atrio-ventricular block after administration of lignocaine in patients treated with prenylamine.
    Grenadier E; Alpan G; Keidar S; Palant A
    Postgrad Med J; 1982 Mar; 58(677):175-7. PubMed ID: 7100044
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ventricular tachycardia: a new iatrogenic possibility.
    Fazzini P; Marchi F
    Am Heart J; 1975 Dec; 90(6):805-6. PubMed ID: 1199926
    [No Abstract]   [Full Text] [Related]  

  • 57. [Two cases of bilateral Horner's syndrome induced by long-term use of the adrenergic neuron blocking agents (author's transl)].
    Oono S; Uga S
    Nippon Ganka Gakkai Zasshi; 1979 Jun; 83(6):521-30. PubMed ID: 484388
    [No Abstract]   [Full Text] [Related]  

  • 58. Self-terminating torsades de pointes or Holter conversion?
    Zugibe FT
    Chest; 1981 Aug; 80(2):250. PubMed ID: 7249784
    [No Abstract]   [Full Text] [Related]  

  • 59. Ventricular arrhythmias caused by prenylamine.
    Puritz R; Henderson MA; Baker SN; Chamberlain DA
    Br Med J; 1977 Sep; 2(6087):608-9. PubMed ID: 902000
    [No Abstract]   [Full Text] [Related]  

  • 60. [Torsades de pointe promoted by atropine].
    Motte G; Laine JF; Sebag C; Davy JM
    Nouv Presse Med; 1982 Nov; 11(48):3571-2. PubMed ID: 7155874
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.